Zhijie Li

16PUBLICATIONS
35CO-AUTHORS
Molecular targetsHealth and ecological risk assessmentGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 01, 2026
The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity.

|Jan 16, 2026
EGFR orchestrates neutrophil activation and NETosis via CEBPβ-dependent PGLYRP1 induction.

Xiaolei Liu, Yue Lu, Yuanbo Guo

|Nov 19, 2025
A Multimodal Energy-Depletion Strategy for Cooperative Tumor Metabolism Regulation in Enhanced Cancer Therapy.

Jingbo Ma, Kun Chen, Xiaoyong Zhang

|Oct 23, 2025
Targeted degradation of endogenous YAP by nanobody bioPROTAC inhibits tumor progression.

Runhua Zhou, Huifang Wang, Gui-Ming Zhang

|Jun 28, 2025
Targeting RAGE with Nanobodies for Molecular Imaging of Cancers and Alzheimer's Disease.

Guangfeng Liang, Fujing Wang, Wei Xiong

|Apr 16, 2025
Nanobody Engineered and Photosensitiser Loaded Bacterial Outer Membrane Vesicles Potentiate Antitumour Immunity and Immunotherapy.

Peng Xia, Chengming Qu, Xiaolong Xu

Pageof 3

Frequent Collaborators

3 joint publications

Jigang Wang

2 joint publications

Haitao Yuan

1 joint publications

Yufeng Yuan

1 joint publications

Yehai An